Research Article
Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
Table 2
Outcomes in patients of HFpEF associated with AF with or without beta-blocker treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
AF, atrial fibrillation; CI, confidence interval; HF, heart failure; HR, hazard ratio; HFpEF, heart failure with preserved ejection fraction. Adjusted by age, sex, smoke, stroke, hypertension, diabetes mellitus, history of acute myocardial infarction, heart rate, brain natriuretic peptide (BNP) level, and pulmonary artery pressure, which were commonly considered the factors to affect clinical outcomes, and also adjusted by diastolic blood pressure and albumin level, which were associated with all-cause mortality in univariate regression analysis. Adjusted by age, sex, smoke, stroke, hypertension, diabetes mellitus, history of acute myocardial infarction, and pulmonary artery pressure, which were the known factors to affect HF rehospitalization, and also adjusted by BNP level and uric acid level, which were associated with HF rehospitalization in univariate regression analysis. |